| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 625154 | 21-Oxabicyclo[16.2.1]heneicosane-4,9,14,18,20-pentaene, 3,6,8,11,13,16-hexaoxo-2,2,7,7,,12,12,17,17-octamethyl- | 0.0241085022307781 | 0.59969295 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0247979034812109 | 0.24183897 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0247979034812109 | 0.262625 |
| NSC 30722 | Pyrimidine, 2,4,6-trichloro-5-methyl- | 0.0247979034812109 | 0.46024099 |
| NSC 339137 | PHYSALOLACTONE | 0.0247979034812109 | 0.39062888 |
| NSC 339579 | 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate | 0.0247979034812109 | 0.12794488 |
| NSC 372155 | 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- | 0.0247979034812109 | 0.38640739 |
| NSC 39215 | Null | 0.0247979034812109 | 0.60156264 |
| NSC 601518 | Null | 0.0247979034812109 | 0.58554289 |
| NSC 636969 | Null | 0.0247979034812111 | 0.3600597 |